EMEA-001579-PIP01-13-M05

Key facts

Invented name
Truberzi
Active substance
Eluxadoline
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0128/2022
PIP number
EMEA-001579-PIP01-13-M05
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of diarrhoea-predominant irritable bowel Syndrome
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

E-mail: paediatricteam@abbvie.com
Tel. +44(0) 1628925033

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating